+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

US Hemophilia B Market and Competitive Landscape - 2022

  • PDF Icon

    Report

  • August 2022
  • Region: United States
  • Fore Pharma
  • ID: 5644599
The report US Hemophilia B Market and Competitive Landscape Highlights - 2022, provides comprehensive insights into Hemophilia B pipeline products, Hemophilia B epidemiology, Hemophilia B market valuations and forecast, Hemophilia B drugs sales and competitive landscape in the US.

The research is classified into seven sections - Hemophilia B treatment options, pipeline products, market analysis comprising of epidemiology, key products marketed, market valuations and forecast, drugs sales and market shares.

Research Scope:

  • Hemophilia B pipeline: Find out the products in clinical trials for the treatment of Hemophilia B by development phase 3, phase 2, and phase 1, by pharmacological class and companies developing the products
  • Hemophilia B epidemiology: Find out the number of patients diagnosed (prevalence) with Hemophilia B in the US
  • Hemophilia B drugs: Identify key products marketed and prescribed for Hemophilia B in the US, including trade name, molecule name, and company
  • Hemophilia B drugs sales: Find out the sales revenues of Hemophilia B drugs in the US
  • Hemophilia B market valuations: Find out the market size for Hemophilia B drugs in 2021 in the US. Find out how the market advanced from 2019 and forecast to 2027
  • Hemophilia B drugs market share: Find out the market shares for key Hemophilia B drugs in the US

Benefits of this Research:

The research helps executives to
  • Support monitoring and reporting national Hemophilia B market analysis and sales trends
  • Track competitor drugs sales and market share in the US Hemophilia B market
  • Track competitive developments in Hemophilia B market and present key issues and learnings
  • Synthesize insights for Hemophilia B market and products to drive business performance
  • Answer key business questions about the Hemophilia B market
  • Evaluate commercial market opportunity assessment, positioning, and segmentation for Hemophilia B products
  • Supports decision making in R&D to long term marketing strategies

Table of Contents

1) Hemophilia B Treatments
2) Hemophilia B Pipeline
3) US Hemophilia B Epidemiology
4) Marketed Drugs for Hemophilia B in US
5) US Hemophilia B Market Size and Forecast
6) US Hemophilia B Products Sales and Forecast
7) US Hemophilia B Market Competitive Landscape
8) Methodology
9) Contact us

List of Tables
1. Hemophilia B Phase 3 Clinical Trials, 2022
2. Hemophilia B Phase 2 Clinical Trials, 2022
3. Hemophilia B Phase 1 Clinical Trials, 2022
4. Hemophilia B Epidemiology, US, 2021 - 2027
5. Marketed Drugs for Hemophilia B, US, 2021
6. Hemophilia B Market Size and Forecast ($), US, 2019 - 2027
7. Hemophilia B Drugs Sales ($), US, 2019 - 2027

List of Figures
1. Hemophilia B Epidemiology, US, 2021 - 2027
2. Hemophilia B Market Size and Forecast ($), US, 2019 - 2027
3. Hemophilia B Drugs Market Share (%), US, 2021